Evaluation of co-morbidities in spondyloarthritis: the ASAS/COMOSpA study The Netherlands

Evaluation of co-morbidities in spondyloarthritis: the ASAS/COMOSpA study The Netherlands - COMOSpA NL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38984

Enrollment

200

Registered

2013-04-24

Start date

2013-06-07

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SpA spondylarthritis spondylarthropathy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Adult (older than 18 years of age) -Classified as spondyloarthritis (SpA) according to the ASAS criteria (either axial or peripheral) --Able to answer the questionnaires -Able to give a written informed consent after reading and understanding the letter of information.

Exclusion criteria

Exclusion criteria: patients not meeting ASAS axial spondyloarthritis criteria or ASAS peripheral spondyloarthritis criteria

Design outcomes

Primary

Measure	Time frame
Assessment of the prevalence of co-morbidities in SpA	—

Countries

Netherlands

Outcome results